FendX Technologies (XCNQ:FNDX) Retained Earnings : C$-8.13 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is FendX Technologies Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. FendX Technologies's retained earnings for the quarter that ended in Mar. 2024 was C$-8.13 Mil.

FendX Technologies's quarterly retained earnings declined from Sep. 2023 (C$-5.81 Mil) to Dec. 2023 (C$-7.02 Mil) and declined from Dec. 2023 (C$-7.02 Mil) to Mar. 2024 (C$-8.13 Mil).

FendX Technologies's annual retained earnings declined from Dec. 2021 (C$-1.46 Mil) to Dec. 2022 (C$-3.36 Mil) and declined from Dec. 2022 (C$-3.36 Mil) to Dec. 2023 (C$-7.02 Mil).

FendX Technologies Retained Earnings Historical Data

The historical data trend for FendX Technologies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FendX Technologies Retained Earnings Chart

FendX Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Retained Earnings

-1.46

-3.36

-7.02

FendX Technologies Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Retained Earnings	Get a 7-Day Free Trial					-4.13	-5.00	-5.81	-7.02	-8.13

FendX Technologies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

FendX Technologies (XCNQ:FNDX) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

FendX Technologies (XCNQ:FNDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » FendX Technologies Inc (XCNQ:FNDX) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

FDXTF:USA E8D:Germany

Address

2010 Winston Park Drive, 2nd Floor, Oakville, ON, CAN, L6H 5R7

Website

https://www.fendxtech.com

FendX Technologies Inc is a technology company focused on developing surface protection products that protect surfaces from pathogen contamination. It is focused on the research, development and commercialization of surface protection coatings using Licensed Technology. The company is currently developing its anticipated first product, REPELWRAP to protect high-contact surfaces from contamination to reduce the transmission of harmful pathogens. The Company has a growing intellectual property portfolio consisting of licensed nonprovisional national stage patent applications.